Oncternal Therapeutics Inc
NASDAQ:ONCT
Income Statement
Earnings Waterfall
Oncternal Therapeutics Inc
Revenue
|
785k
USD
|
Operating Expenses
|
-42.5m
USD
|
Operating Income
|
-41.7m
USD
|
Other Expenses
|
2.2m
USD
|
Net Income
|
-39.5m
USD
|
Income Statement
Oncternal Therapeutics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+143%
|
2
+47%
|
2
+45%
|
3
+4%
|
2
-2%
|
3
+2%
|
3
+34%
|
4
+5%
|
4
+7%
|
5
+40%
|
4
-19%
|
4
N/A
|
4
-16%
|
2
-48%
|
1
-21%
|
1
-37%
|
1
-9%
|
1
-23%
|
1
+19%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(44)
|
(40)
|
(38)
|
(34)
|
(30)
|
(26)
|
(20)
|
(21)
|
(22)
|
(23)
|
(24)
|
(25)
|
(26)
|
(26)
|
(27)
|
(28)
|
(31)
|
(38)
|
(42)
|
(43)
|
(39)
|
(28)
|
(40)
|
(36)
|
(36)
|
(38)
|
(22)
|
(21)
|
(21)
|
(22)
|
(25)
|
(32)
|
(36)
|
(40)
|
(43)
|
(43)
|
(46)
|
(48)
|
(46)
|
(45)
|
(42)
|
|
Selling, General & Administrative |
(11)
|
(11)
|
(11)
|
(10)
|
(9)
|
(9)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(9)
|
(8)
|
(7)
|
(7)
|
(7)
|
(9)
|
(10)
|
(9)
|
(8)
|
(9)
|
(10)
|
(10)
|
(12)
|
(12)
|
(12)
|
(13)
|
(13)
|
(13)
|
(13)
|
(13)
|
(13)
|
|
Research & Development |
(32)
|
(29)
|
(27)
|
(24)
|
(21)
|
(17)
|
(13)
|
(13)
|
(14)
|
(15)
|
(16)
|
(17)
|
(17)
|
(17)
|
(18)
|
(19)
|
(21)
|
(28)
|
(32)
|
(33)
|
(30)
|
(21)
|
(33)
|
(29)
|
(28)
|
(29)
|
(12)
|
(12)
|
(13)
|
(14)
|
(15)
|
(21)
|
(24)
|
(27)
|
(31)
|
(30)
|
(33)
|
(35)
|
(33)
|
(32)
|
(30)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(44)
N/A
|
(40)
+8%
|
(38)
+5%
|
(34)
+11%
|
(30)
+11%
|
(26)
+13%
|
(20)
+23%
|
(21)
-4%
|
(22)
-2%
|
(23)
-5%
|
(24)
-5%
|
(25)
-4%
|
(26)
-4%
|
(26)
-1%
|
(27)
-1%
|
(28)
-6%
|
(31)
-9%
|
(38)
-24%
|
(42)
-10%
|
(43)
-3%
|
(39)
+9%
|
(28)
+29%
|
(39)
-41%
|
(35)
+12%
|
(33)
+4%
|
(36)
-7%
|
(19)
+45%
|
(19)
+3%
|
(18)
+7%
|
(19)
-7%
|
(21)
-11%
|
(26)
-25%
|
(31)
-20%
|
(35)
-13%
|
(39)
-12%
|
(41)
-4%
|
(45)
-9%
|
(47)
-5%
|
(45)
+5%
|
(44)
+2%
|
(42)
+5%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
|
Total Other Income |
1
|
1
|
1
|
1
|
(9)
|
(6)
|
(49)
|
(9)
|
3
|
9
|
52
|
11
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(42)
N/A
|
(39)
+9%
|
(37)
+5%
|
(33)
+11%
|
(39)
-21%
|
(33)
+17%
|
(70)
-113%
|
(30)
+57%
|
(19)
+38%
|
(14)
+24%
|
28
N/A
|
(14)
N/A
|
(18)
-26%
|
(26)
-47%
|
(26)
-1%
|
(28)
-6%
|
(30)
-9%
|
(38)
-24%
|
(41)
-10%
|
(42)
-2%
|
(38)
+9%
|
(27)
+29%
|
(40)
-47%
|
(35)
+11%
|
(34)
+4%
|
(37)
-7%
|
(19)
+47%
|
(19)
+3%
|
(17)
+9%
|
(18)
-7%
|
(21)
-12%
|
(26)
-25%
|
(31)
-21%
|
(35)
-13%
|
(39)
-12%
|
(41)
-4%
|
(44)
-8%
|
(46)
-4%
|
(43)
+6%
|
(42)
+3%
|
(39)
+5%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(42)
|
(39)
|
(37)
|
(33)
|
(39)
|
(33)
|
(70)
|
(30)
|
(19)
|
(14)
|
28
|
(14)
|
(18)
|
(26)
|
(26)
|
(28)
|
(30)
|
(38)
|
(41)
|
(42)
|
(38)
|
(27)
|
(40)
|
(35)
|
(34)
|
(37)
|
(19)
|
(19)
|
(17)
|
(18)
|
(21)
|
(26)
|
(31)
|
(35)
|
(39)
|
(41)
|
(44)
|
(46)
|
(43)
|
(42)
|
(39)
|
|
Net Income (Common) |
(42)
N/A
|
(39)
+9%
|
(37)
+5%
|
(33)
+11%
|
(39)
-21%
|
(33)
+17%
|
(70)
-113%
|
(30)
+57%
|
(19)
+38%
|
(14)
+24%
|
28
N/A
|
(14)
N/A
|
(18)
-26%
|
(26)
-47%
|
(26)
-1%
|
(28)
-6%
|
(30)
-9%
|
(38)
-24%
|
(41)
-10%
|
(42)
-2%
|
(38)
+9%
|
(27)
+29%
|
(40)
-47%
|
(35)
+11%
|
(34)
+4%
|
(37)
-7%
|
(19)
+47%
|
(19)
+3%
|
(17)
+9%
|
(18)
-7%
|
(21)
-12%
|
(26)
-25%
|
(31)
-21%
|
(35)
-13%
|
(39)
-12%
|
(41)
-4%
|
(44)
-8%
|
(46)
-4%
|
(43)
+6%
|
(42)
+3%
|
(39)
+5%
|
|
EPS (Diluted) |
-7.03
N/A
|
-5.79
+18%
|
-4.86
+16%
|
-4.29
+12%
|
-4.82
-12%
|
-2.33
+52%
|
-4.97
-113%
|
-1.93
+61%
|
-1.33
+31%
|
-0.99
+26%
|
1.95
N/A
|
-1
N/A
|
-1.22
-22%
|
-1.62
-33%
|
-1.64
-1%
|
-1.73
-5%
|
-1.75
-1%
|
-1.71
+2%
|
-1.77
-4%
|
-1.75
+1%
|
-0.24
+86%
|
-7.38
-2 975%
|
-5.9
+20%
|
-2.31
+61%
|
-3.31
-43%
|
-2.38
+28%
|
-1.19
+50%
|
-0.93
+22%
|
-0.85
+9%
|
-0.37
+56%
|
-0.41
-11%
|
-0.52
-27%
|
-0.64
-23%
|
-0.71
-11%
|
-0.78
-10%
|
-0.75
+4%
|
-0.84
-12%
|
-0.78
+7%
|
-0.73
+6%
|
-0.72
+1%
|
-13.43
-1 765%
|